Yatırımcı.AI

HGH vs SHU Fund Comparison

Price, period returns, size, investor count and risk score of HGH (Hedef Portföy Güneş Hisse Senedi Serbest (TL) Fon (Hisse Senedi Yoğun Fon)) and SHU (Sparta Portföy Üçüncü Hisse Senedi Serbest (TL) Fon (Hisse Senedi Yoğun Fon)) side by side.

SPK decided to liquidate HGH in bulletin 2026/60 dated September 17, 2026; no buy or redemption orders are executed in the fund. Its returns in this comparison are based on the last price published on TEFAS (November 2, 2026). HGH fund page · SPK bulletin 2026/60

HGHSHU
StockFund

If You Had Invested TRY 10,000

Metric Comparison

HGH vs SHU Fund Comparison
MetricHGHSHUCategory median
Today (est.)—0.99%1.71%
Daily−14.61%0.00%0.16%
1 week−20.49%1.30%0.46%
1 month−90.18%−16.22%1.10%
3 months−90.27%−34.90%3.53%
6 months−90.42%−36.23%8.53%
YTD−89.42%−11.11%16.18%
1 year−90.41%—19.94%
3 years−92.12%—103.56%
Returns are based on prices as of November 2, 2026; the fund with the higher return or the lower risk score counts as the leader. Today (est.): live estimated return of funds with at least 50% coverage, last calculated Nov 2, 2026, 15:49.

Popular Comparisons

Popular Fund Comparisons

Related Pages

About the HGH vs SHU Comparison

The price, returns, size and risk of HGH (Hedef Portföy Güneş Hisse Senedi Serbest (TL) Fon (Hisse Senedi Yoğun Fon)) and SHU (Sparta Portföy Üçüncü Hisse Senedi Serbest (TL) Fon (Hisse Senedi Yoğun Fon)) are compared side by side as of November 2, 2026. Of the 8 metrics compared, HGH leads in 2 and SHU leads in 6. HGH is a Hedge Fund fund managed by Hedef Portföy Yönetimi A.Ş.; SHU is a Hedge Fund fund managed by Sparta Portföy Yönetimi A.Ş..

Highlights: Daily: SHU leads (0.00% vs −14.61%). 1 week: SHU leads (1.30% vs −20.49%). 1 month: SHU leads (−16.22% vs −90.18%). 3 months: SHU leads (−34.90% vs −90.27%). 6 months: SHU leads (−36.23% vs −90.42%). YTD: SHU leads (−11.11% vs −89.42%). Size (TRY): HGH leads (96.8K vs 2.3K). Investors: HGH leads (19 vs 1).

Frequently Asked Questions

Year to date HGH returned −89.42% and SHU returned −11.11%; over the last year HGH returned −90.41% and SHU returned —. Over the last month HGH returned −90.18% and SHU returned −16.22%. Past performance does not indicate future returns.

As of November 2, 2026, HGH has a size of TRY 96.8K with 19 investors, while SHU has a size of TRY 2.3K with 1 investors. HGH leads in size and HGH leads in investor count.

The CMB risk score of HGH is 7 out of 7 and that of SHU is 7. The risk score reflects the historical volatility of the fund price; 1 is the lowest and 7 the highest risk. A lower score means less volatility, not a guarantee of higher returns.